What does Lite Strategy, Inc. do?
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. It is also involved in holding Litecoin tokens as a primary reserve asset. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite…
What is Lite Strategy, Inc.'s P/E and P/B ratio?
Lite Strategy, Inc. has a P/E ratio of -0.6 and a P/B ratio of 0.64.
What is Lite Strategy, Inc.'s debt-to-equity ratio?
Lite Strategy, Inc. has a debt-to-equity ratio of 0.00.
How much does Lite Strategy, Inc. owe compared with what it owns?
Lite Strategy, Inc. owes $0.02 for every $1 it owns (balance sheet Mar 2026), which is low.
What is Lite Strategy, Inc.'s Positivity rank?
Lite Strategy, Inc. is ranked #3,052 of 6,774 companies globally and #1,181 of 4,000 in United States on PositoAI, with a Positivity Score of 20,904.
Does Lite Strategy, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
Lite Strategy, Inc. has no active red flags. It has 1 yellow flag (PosiYellow stress signals, 2/10 points): Change of auditor (8-K Item 4.01).
Where can I read the latest news about Lite Strategy, Inc.?
Recent headlines about Lite Strategy, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Lite Strategy, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Lite Strategy, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.